Does an elemental diet affect operation and/or recurrence rate in Crohn's disease in Japan?

Journal of Gastroenterology

Volumn 38, Issue 10, 2003, Pages 1019-1021

  Ogata, Haruhiko ^a   Hibi, Toshifumi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCINEURIN; CORTICOSTEROID; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 6 RECEPTOR; MACROLIDE; MERCAPTOPURINE; MONOCLONAL ANTIBODY; NUCLEOTIDE BINDING PROTEIN; STEROID; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

CLINICAL TRIAL; COLON SURGERY; CORTICOSTEROID THERAPY; CROHN DISEASE; DIET SUPPLEMENTATION; DIET THERAPY; DISEASE ACTIVITY; DISEASE COURSE; DRUG EFFICACY; DRUG MECHANISM; EDITORIAL; ELEMENTAL DIET; GENE MUTATION; HUMAN; IMMUNOTHERAPY; JAPAN; MORTALITY; NUTRITIONAL STATUS; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RECURRENCE RISK; REMISSION; SIDE EFFECT; STEROID THERAPY;

COLECTOMY; CROHN DISEASE; FOOD, FORMULATED; HUMANS; ILEITIS; INCIDENCE; JAPAN; PROGNOSIS; RECURRENCE; TREATMENT OUTCOME; UNITED STATES;

EID: 0344393614     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00535-003-1210-z     Document Type: Editorial

References (17)

1. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603.
2. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-6.
3. Hisamatsu T, Suzuki M, Reinecker HC, Nadeau WJ, McCormick BA, Podolsky DK. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 2003;124:993-1000.
4. Hampe J, Cuthbert A, Croucher PJ, Mirza MM, Mascheretti S, Fisher S, et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 2001;357:1925-8.
5. Lesage S, Zouali H, Cezard JP, Colombel JF, Belaiche J, Almer S, et al. EPWG-IBD Group; EPIMAD Group; GETAID Group. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002;70:845-57.
6. Ahmad T, Armuzzi A, Bunce M, Mulcahy-Hawes K, Marshall SE, Orchard TR, et al. The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology 2002;122: 854-66.
7. Abreu MT, Taylor KD, Lin YC, Hang T, Gaiennie J, Landers CJ, et al. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Gastroenterology 2002;123: 679-88.
8. Louis E, Michel V, Hugot JP, Reenaers C, Fontaine F, Delforge M, et al. Early development of stricturing or penetrating pattern in Crohn's disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype. Gut 2003;52:552-7.
9. Inoue N, Tamura K, Kinouchi Y, Fukuda Y, Takahashi S, Ogura Y, et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 2002;123:86-91.
10. Yamazaki K, Takazoe M, Tanaka T, Kazumori T, Nakamura Y. Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease. J Hum Genet 2002;47: 469-72.
11. Leong RW, Armuzzi A, Ahmad T, Wong ML, Tse P, Jewell DP, et al. NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population. Aliment Pharmacol Ther 2003;17: 1465-70.
12. Oriuchi T, Hiwatashi N, Kinouchi Y, Takahashi S, Takagi S, Negoro K, et al. Clinical course and longterm prognosis of Japanese patients with Crohn's disease: predictive factors, rates of operation, and mortality. J Gastroenterol 2003;38:942-53.
13. Lochs H, Steinhardt HJ, Klaus-Wentz B, Zeitz M, Vogelsang H, Sommer H, et al. Comparison of enteral nutrition and drug treatment in active Crohn's disease. Results of the European Cooperative Crohn's Disease Study. IV. Gastroenterology 1991;101:881-8.
14. Verma S, Holdsworth CD, Giaffer MH. Does adjuvant nutritional support diminish steroid dependency in Crohn disease? Scand J Gastroenterol 2001;36:383-8.
15. Ikeuchi H, Kusunoki M, Yanagi H, Yamamura T, Fukuda Y, Shimoyama T. Effects of elemental diet (ED) on surgical treatment in Crohn's disease. Hepatogastroenterology 2000;47:390-2.
16. Targan SR, Hanauer SB, van Deventer SJ, Mayer L, Present DH, Braakman T, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 1997;337:1029-35.
17. Ierardi E, Principi M, Francavilla R, Pisani A, Rendina M, Ingrosso M, et al. Oral tacrolimus long-term therapy in patients with Crohn's disease and steroid resistance. Aliment Pharmacol Ther 2001;15:371-7.